RBC Capital analyst Matthew Hedberg maintained a Buy rating on Dynatrace (DT – Research Report) on January 20 and set a price target of $65.00.

In a report released yesterday, Deane Dray from RBC Capital maintained a Sell rating on 3M (MMM – Research Report), with a price target of ...

On Thursday, RBC Capital Markets adjusted its outlook on shares of JPMorgan Chase & Co. (NYSE: NYSE:JPM) shares by increasing the price target to $260 from the previous $248, while retaining an ...

While Biogen has made an opportunistic bid for partner Sage, its top executive seemed to play down the urgency for his ...

In his latest memo named “On Bubble Watch,” Howard Marks, co-founder and co-chairman of Oaktree Capital, highlighted several ...

In his latest memo named “On Bubble Watch,” Howard Marks, co-founder and co-chairman of Oaktree Capital ... According to the JP Morgan report, AI investing: More broadening than bubble ...

Dyne Therapeutics Inc (DYN) stock saw a decline, ending the day at $14.13 which represents a decrease of $-0.64 or -4.33% from the prior close of $14.77. The stock opened at $14.89 and touched a low ...

According to the JP Morgan report, AI investing ... connects buyers with global suppliers for efficient production. RBC Capital increased its price target for Xometry, Inc. (NASDAQ:XMTR) from ...

We recently compiled a list of the 13 AI News and Ratings on Wall Street’s Radar. In this article, we are going to take a ...